Incyte <INCY.O>: Leerink Partners raises target price to $155 from $131
INCY•Related News
Supernus, Indivior merge to strengthen neuroscience drug portfolio
SUPN•
Regenxbio schedules conference call to discuss second-quarter results and operational update
RGNX•
Lindblad Expeditions Q2 Adjusted EBITDA USD 32.463 Million Vs. IBES Estimate USD 23.8 Million
LIND•
Galaxy Digital Inc <GLXY.O>: Rosenblatt Securities cuts target price to $35 from $39
GLXY•
Navigator Gas lines up USD 121.8 million financing for two newbuild ammonia carriers in Amon joint venture
NVGS•